Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (261-270 of 300) with videos related to

Pageof 30
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy VolunteersMyron M Levine, Salim Abdullah, Yaseen M Arabi, et al.
Clinical & Translational Immunology|January 28, 2025
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccinationNicole L Messina, Susie Germano, Amy W Chung, et al.
NPJ Vaccines|January 17, 2025
Antibody responses against influenza A decline with successive years of annual influenza vaccinationSheena G Sullivan, Arseniy Khvorov, Louise Carolan, et al.
Elife|September 25, 2024
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea L Hansen, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
JAMA Network Open|March 9, 2022
Comparison of Seroconversion in Children and Adults With Mild COVID-19Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
Pageof 30

Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy VolunteersMyron M Levine, Salim Abdullah, Yaseen M Arabi, et al.
Clinical & Translational Immunology|January 28, 2025
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccinationNicole L Messina, Susie Germano, Amy W Chung, et al.
NPJ Vaccines|January 17, 2025
Antibody responses against influenza A decline with successive years of annual influenza vaccinationSheena G Sullivan, Arseniy Khvorov, Louise Carolan, et al.
Elife|September 25, 2024
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea L Hansen, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
JAMA Network Open|March 9, 2022
Comparison of Seroconversion in Children and Adults With Mild COVID-19Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
Pageof 30